Health

Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study

Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study

Virologists from the KU Leuven Rega Institute in Belgium have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters.

Click here to read more -->
×